Stephanie Norris, MD | |
3007 Harbor Ln N, Plymouth, MN 55447-5103 | |
(952) 993-8900 | |
Not Available |
Full Name | Stephanie Norris |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 24 Years |
Location | 3007 Harbor Ln N, Plymouth, Minnesota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093782716 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 41320 (Minnesota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Park Nicollet Methodist Hospital Care Svcs | Saint louis park, MN | Home health agency |
Park Nicollet Methodist Hospital | Saint louis park, MN | Hospice |
Park Nicollet Methodist Hospital | Saint louis park, MN | Hospital |
Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Park Nicollet Clinic | 7911819438 | 1529 |
News Archive
Ultrasound-stimulated microbubbles have been showing promise in recent years as a non-invasive way to break up dangerous blood clots. But though many researchers have studied the effectiveness of this technique, not much was understood about why it works. Now a team of researchers in Toronto has collected the first direct evidence showing how these wiggling microbubbles cause a blood clot's demise. The team's findings are featured in the AIP Publishing journal Applied Physics Letters.
Chemotherapy is an integral part of modern cancer treatment, but it's not always effective.
A new optogenetic technology developed at UMass Medical School, called optogenetic immunomodulation, is capable of turning on immune cells to attack melanoma tumors in mice. Using near-infrared light, UMMS researchers have shown they can selectively activate an immune response by controlling the flow of calcium ions into the cell. This breakthrough could lead to less invasive, and more controlled and selective, immunotherapies for cancer treatment.
The investigational drug axitinib produced tumor regression or stable disease in almost three-out-of-four patients with advanced thyroid cancer, a research team reported at the annual meeting of the American Society for Clinical Oncology in Chicago.
Frequent testing and treatment of infection does not reduce the prevalence of chlamydia in urban teenage girls, according to a long term study by Indiana University School of Medicine researchers published in the January 1, 2010 issue of the Journal of Infectious Diseases.
› Verified 7 days ago
Entity Name | Park Nicollet Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780621904 PECOS PAC ID: 7911819438 Enrollment ID: O20031104000046 |
News Archive
Ultrasound-stimulated microbubbles have been showing promise in recent years as a non-invasive way to break up dangerous blood clots. But though many researchers have studied the effectiveness of this technique, not much was understood about why it works. Now a team of researchers in Toronto has collected the first direct evidence showing how these wiggling microbubbles cause a blood clot's demise. The team's findings are featured in the AIP Publishing journal Applied Physics Letters.
Chemotherapy is an integral part of modern cancer treatment, but it's not always effective.
A new optogenetic technology developed at UMass Medical School, called optogenetic immunomodulation, is capable of turning on immune cells to attack melanoma tumors in mice. Using near-infrared light, UMMS researchers have shown they can selectively activate an immune response by controlling the flow of calcium ions into the cell. This breakthrough could lead to less invasive, and more controlled and selective, immunotherapies for cancer treatment.
The investigational drug axitinib produced tumor regression or stable disease in almost three-out-of-four patients with advanced thyroid cancer, a research team reported at the annual meeting of the American Society for Clinical Oncology in Chicago.
Frequent testing and treatment of infection does not reduce the prevalence of chlamydia in urban teenage girls, according to a long term study by Indiana University School of Medicine researchers published in the January 1, 2010 issue of the Journal of Infectious Diseases.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Stephanie Norris, MD 3800 Park Nicollet Blvd, Credentialing, St Louis Park, MN 55416-2527 Ph: () - | Stephanie Norris, MD 3007 Harbor Ln N, Plymouth, MN 55447-5103 Ph: (952) 993-8900 |
News Archive
Ultrasound-stimulated microbubbles have been showing promise in recent years as a non-invasive way to break up dangerous blood clots. But though many researchers have studied the effectiveness of this technique, not much was understood about why it works. Now a team of researchers in Toronto has collected the first direct evidence showing how these wiggling microbubbles cause a blood clot's demise. The team's findings are featured in the AIP Publishing journal Applied Physics Letters.
Chemotherapy is an integral part of modern cancer treatment, but it's not always effective.
A new optogenetic technology developed at UMass Medical School, called optogenetic immunomodulation, is capable of turning on immune cells to attack melanoma tumors in mice. Using near-infrared light, UMMS researchers have shown they can selectively activate an immune response by controlling the flow of calcium ions into the cell. This breakthrough could lead to less invasive, and more controlled and selective, immunotherapies for cancer treatment.
The investigational drug axitinib produced tumor regression or stable disease in almost three-out-of-four patients with advanced thyroid cancer, a research team reported at the annual meeting of the American Society for Clinical Oncology in Chicago.
Frequent testing and treatment of infection does not reduce the prevalence of chlamydia in urban teenage girls, according to a long term study by Indiana University School of Medicine researchers published in the January 1, 2010 issue of the Journal of Infectious Diseases.
› Verified 7 days ago
Erica N. Roberson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15700 37th Ave N, #300, Plymouth, MN 55446 Phone: 612-871-1145 Fax: 612-870-5491 | |
Dr. Thomas John Kaminsky, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15700 37th Ave N Ste 300, Plymouth, MN 55446 Phone: 612-871-1145 Fax: 612-870-5491 | |
Alfred P. Chiang, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Campus Dr, Suite 100, Plymouth, MN 55441 Phone: 763-519-0634 Fax: 763-519-0636 | |
Mr. Bradley Daniel Chmielewski, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2800 Campus Dr Ste 10, Plymouth, MN 55441 Phone: 763-559-2171 | |
Daniela T Ouzounova, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2855 Campus Dr, Ste. 400, Plymouth, MN 55441 Phone: 763-577-7400 | |
Dr. Daniel Mark Van Handel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15700 37th Ave N Ste 300, Plymouth, MN 55446 Phone: 612-871-1145 Fax: 612-870-5491 |